The German drug maker Bayer (BAYN) said that it planned to spin off its polymer business into a new, publicly listed entity as the company moves to shift its focus primarily to health care. Source: Filing
Spin-Off
Actionable Opportunities in Special Situations: Spinoffs, Bankruptcy, Restructurings
